National Institute of General Medical Sciences; Notice of Closed Meetings, 48819-48820 [2016-17561]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 143 / Tuesday, July 26, 2016 / Notices
We estimate the burden for the
preparation of each record to be .10
hours for a total burden of 2,400 hours.
We estimate that all processors
(15,000 processors) will maintain
records of the calibration of processmonitoring instruments and the
performing of any periodic end-product
and in-process testing (§ 123.8(d)) at 47
records per processor for a total of
705,000 records. We estimate the
burden for the preparation of each
record to be .10 hours for a total burden
of 70,500 hours.
We estimate that all processors
(15,000 processors) will maintain
sanitation control records (§ 123.11(c))
at 280 records per processor for a total
of 4,200,000 records. We estimate the
burden for the preparation of each
record to be .10 hours for a total burden
of 420,000 hours.
We estimate that all importers (4,100
importers) will maintain records that
verify that the fish and fishery products
they offer for import into the United
States were processed in accordance
with the HACCP and sanitation
provisions set forth in part 123
(§ 123.12(c)). We estimate that 80
records will be prepared per importer
for a total of 328,000 records. We
estimate the burden for the preparation
of each record to be .10 hours for a total
burden of 32,800 hours.
We estimate that 1 percent of all
importers (41 importers) will require
new written verification procedures to
verify compliance of imports
(§ 123.12(a)(2)). We estimate the burden
for preparing the new procedures to be
4 hours per importer for a total burden
of 164 hours.
Dated: July 19, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–17571 Filed 7–25–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
Presidential Commission for
the Study of Bioethical Issues, Office of
the Assistant Secretary for Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice of meeting.
srobinson on DSK5SPTVN1PROD with NOTICES
AGENCY:
The Presidential Commission
for the Study of Bioethical Issues (the
Commission) will conduct its twentysixth meeting on August 31, 2016. At
this meeting, the Commission will
SUMMARY:
VerDate Sep<11>2014
20:28 Jul 25, 2016
Jkt 238001
reflect on the past, present, and future
impact of national bioethics advisory
bodies. Topics will include the history
of national bioethics advisory bodies
and their contributions to health policy,
perspectives about similar bodies
elsewhere, and discussion about what
the future holds for groups like the
Commission.
DATES: The meeting will take place
August 31, 2016, from 9 a.m. to
approximately 4 p.m.
ADDRESSES: Annenberg Public Policy
Center, 202 S. 36th St., Philadelphia, PA
19104.
FOR FURTHER INFORMATION CONTACT: Lisa
M. Lee, Executive Director, Presidential
Commission for the Study of Bioethical
Issues, 330 C Street SW., Suite L001,
Washington, DC 20201. Telephone:
202–795–7689. Email: Lisa.Lee@
bioethics.gov. Additional information
may be obtained at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
twenty-sixth meeting of the
Commission. The meeting will be open
to the public with attendance limited to
space available. The meeting will also
be webcast at www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the Commission.
The Commission is an expert panel of
not more than 13 members who are
drawn from the fields of bioethics,
science, medicine, technology,
engineering, law, philosophy, theology,
or other areas of the humanities or
social sciences. The Commission
advises the President on bioethical
issues arising from advances in
biomedicine and related areas of science
and technology. The Commission seeks
to identify and promote policies and
practices that ensure scientific research,
health care delivery, and technological
innovation are conducted in a socially
and ethically responsible manner.
The main agenda for the
Commission’s twenty-sixth meeting is to
reflect upon the role of national
bioethics advisory bodies, both in the
US and abroad, in the past, present, and
future.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it.
Respectful consideration of opposing
views and active participation by
citizens in public exchange of ideas
enhances overall public understanding
of the issues at hand and conclusions
reached by the Commission. The
Commission is particularly interested in
receiving comments and questions
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
48819
during the meeting that are responsive
to specific sessions. Written comments
will be accepted in advance, during, and
after the meeting and are especially
welcome. Comments will be publicly
available, including any personally
identifiable or confidential business
information that they contain. Trade
secrets should not be submitted.
Written comments will be accepted by
email to info@bioethics.gov, or by mail
to the following address: Public
Commentary, Presidential Commission
for the Study of Bioethical Issues, 330
C Street SW., Suite L001, Washington,
DC 20201. To accommodate as many
individuals as possible, the time for
each question or comment may be
limited. If the number of individuals
wishing to pose a question or make a
comment is greater than can reasonably
be accommodated during the scheduled
meeting, the Commission may make a
random selection. Time permitting, we
will read aloud as many comments as
possible.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify Esther Yoo by telephone
at (202) 795–7689, or email at
Esther.Yoo@bioethics.gov at least one
week in advance of the meeting. The
Commission will make every effort to
accommodate persons who need special
assistance.
Dated: July 8, 2016.
Lisa M. Lee,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2016–17620 Filed 7–25–16; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\26JYN1.SGM
26JYN1
48820
Federal Register / Vol. 81, No. 143 / Tuesday, July 26, 2016 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
srobinson on DSK5SPTVN1PROD with NOTICES
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Conduct the initial scientific peer
review and assess the merit of Research
Centers in Injury and Peri-operative Sciences.
Date: August 2, 2016.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Lisa A. Newman, SCD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, Building 45, Room 3AN18,
Bethesda, MD 20892–4874, (301)435–0965,
newmanla2@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Conduct the initial scientific peer
review and assess the merit of Clinical Trail
Research Project Grants.
Date: August 4, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Lisa A. Newman, SCD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, Building 45, Room 3AN18,
Bethesda, MD 20892–4874, (301)435–0965,
newmanla2@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: July 20, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–17561 Filed 7–25–16; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
20:28 Jul 25, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI K08 Review Meeting.
Date: August 15, 2016.
Time: 12:00 p.m. to 12:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7186, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Keith A. Mintzer, Ph.D.,
Scientific Review Officer, Office of Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7186, Bethesda, MD 20892–7924, 301–594–
7947, mintzerk@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 20, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Support of Competitive Research
(SCORE).
Date: August 2, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3An.12N, 45 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Margaret J. Weidman,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18B, Bethesda, MD
20892, 301–594–3663, weidmanma@
nigms.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: July 20, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–17560 Filed 7–25–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–17548 Filed 7–25–16; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 81, Number 143 (Tuesday, July 26, 2016)]
[Notices]
[Pages 48819-48820]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-17561]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 48820]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Conduct the initial scientific peer
review and assess the merit of Research Centers in Injury and Peri-
operative Sciences.
Date: August 2, 2016.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Lisa A. Newman, SCD, Scientific Review Officer,
Office of Scientific Review, National Institute of General Medical
Sciences, Building 45, Room 3AN18, Bethesda, MD 20892-4874,
(301)435-0965, newmanla2@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel, Conduct the initial scientific peer
review and assess the merit of Clinical Trail Research Project
Grants.
Date: August 4, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Lisa A. Newman, SCD, Scientific Review Officer,
Office of Scientific Review, National Institute of General Medical
Sciences, Building 45, Room 3AN18, Bethesda, MD 20892-4874,
(301)435-0965, newmanla2@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859, Biomedical Research and
Research Training, National Institutes of Health, HHS)
Dated: July 20, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-17561 Filed 7-25-16; 8:45 am]
BILLING CODE 4140-01-P
